McKinsey to pay $650m to settle US opioid consulting probeMcKinsey will pay $650 million for advising Purdue Pharma on OxyContin sales, reflecting its role in the opioid crisis.
Purdue Pharma files a new $7 billion bankruptcy plan to settle opioid lawsuitsPurdue Pharma seeks bankruptcy judge's approval for a revised opioid crisis settlement plan involving the Sackler family.The Sacklers agree to relinquish ownership and contribute $7 billion over 15 years.
Purdue Pharma to Pay $7.4 Billion Over the Toll of OxyContin | KQEDPurdue Pharma and the Sackler family agreed to a $7.4 billion settlement over lawsuits related to OxyContin.
McKinsey to pay $650m to settle US opioid consulting probeMcKinsey will pay $650 million for advising Purdue Pharma on OxyContin sales, reflecting its role in the opioid crisis.
Purdue Pharma files a new $7 billion bankruptcy plan to settle opioid lawsuitsPurdue Pharma seeks bankruptcy judge's approval for a revised opioid crisis settlement plan involving the Sackler family.The Sacklers agree to relinquish ownership and contribute $7 billion over 15 years.
Purdue Pharma to Pay $7.4 Billion Over the Toll of OxyContin | KQEDPurdue Pharma and the Sackler family agreed to a $7.4 billion settlement over lawsuits related to OxyContin.